Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hematology Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hematology Drugsmarket, defines the market attractiveness level of Hematology Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hematology Drugs industry, describes the types of Hematology Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hematology Drugs market and the development prospects and opportunities of Hematology Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hematology Drugs market in Chapter 13.
By Player:
Johnson & Johnson
AbbVie
Celgene
Bristol-Myers Squibb
Takeda
GSK
Novartis
Roche
Pfizer
Sanof
By Type:
OTC
Rx Drugs
By End-User:
Hospital
Drugs Stores
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hematology Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hematology Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hematology Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hematology Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hematology Drugs Market Analysis and Outlook to 2022
-
7.1 Global Hematology Drugs Consumption (2017-2022)
-
7.2 United States Hematology Drugs Consumption (2017-2022)
-
7.3 Europe Hematology Drugs Consumption (2017-2022)
-
7.4 China Hematology Drugs Consumption (2017-2022)
-
7.5 Japan Hematology Drugs Consumption (2017-2022)
-
7.6 India Hematology Drugs Consumption (2017-2022)
-
7.7 South Korea Hematology Drugs Consumption (2017-2022)
8 Region and Country-wise Hematology Drugs Market Analysis and Outlook to 2028
-
8.1 Global Hematology Drugs Consumption Forecast (2022-2028)
-
8.2 United States Hematology Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Hematology Drugs Consumption Forecast (2022-2028)
-
8.4 China Hematology Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Hematology Drugs Consumption Forecast (2022-2028)
-
8.6 India Hematology Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Hematology Drugs Consumption Forecast (2022-2028)
9 Global Hematology Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Hematology Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global OTC Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Rx Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Hematology Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drugs Stores Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Hematology Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Hematology Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Rx Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hematology Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drugs Stores Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Hematology Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hematology Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hematology Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hematology Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hematology Drugs Market Competitive Analysis
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Details
-
14.1.2 Johnson & Johnson Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson Hematology Drugs Product and Service
-
14.2 AbbVie
-
14.2.1 AbbVie Company Details
-
14.2.2 AbbVie Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AbbVie Hematology Drugs Product and Service
-
14.3 Celgene
-
14.3.1 Celgene Company Details
-
14.3.2 Celgene Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Celgene Hematology Drugs Product and Service
-
14.4 Bristol-Myers Squibb
-
14.4.1 Bristol-Myers Squibb Company Details
-
14.4.2 Bristol-Myers Squibb Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bristol-Myers Squibb Hematology Drugs Product and Service
-
14.5 Takeda
-
14.5.1 Takeda Company Details
-
14.5.2 Takeda Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Takeda Hematology Drugs Product and Service
-
14.6 GSK
-
14.6.1 GSK Company Details
-
14.6.2 GSK Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GSK Hematology Drugs Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis Hematology Drugs Product and Service
-
14.8 Roche
-
14.8.1 Roche Company Details
-
14.8.2 Roche Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Roche Hematology Drugs Product and Service
-
14.9 Pfizer
-
14.9.1 Pfizer Company Details
-
14.9.2 Pfizer Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Pfizer Hematology Drugs Product and Service
-
14.10 Sanof
-
14.10.1 Sanof Company Details
-
14.10.2 Sanof Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sanof Hematology Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hematology Drugs
-
Figure Hematology Drugs Picture
-
Table Global Hematology Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hematology Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hematology Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hematology Drugs Consumption by Country (2017-2022)
-
Figure United States Hematology Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Hematology Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Hematology Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Hematology Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Hematology Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hematology Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hematology Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Hematology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hematology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hematology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hematology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hematology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hematology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global OTC Consumption and Growth Rate (2017-2022)
-
Figure Global Rx Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global OTC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rx Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hematology Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hematology Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Hematology Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Hematology Drugs Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Hematology Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Hematology Drugs Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Hematology Drugs Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Hematology Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Hematology Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Hematology Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Hematology Drugs Product and Service
-
Table Sanof (Foundation Year, Company Profile and etc.)
-
Table Sanof Hematology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanof Hematology Drugs Product and Service
-
